PMA device
Adiana Permanent Contraception System
Hologic, Inc. · Laparoscopic Contraceptive Tubal Occlusion Device (KNH, Class III) · First FDA decision Apr 15, 2010, newest Feb 9, 2012Contraception
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
2
Naming "Adiana Permanent Contraception"
MAUDE reports
6
Brand "Adiana Permanent Contraception", since 2015
PubMed studies
8
Mentioning "Adiana Permanent Contraception"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Adiana Permanent Contraception System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- ADIANA PERMANENT CONTRACEPTION SYSTEMPMA supplement
P070022-S026 · Decided Feb 9, 2012 · 23 days after receipt · Normal 180 Day Track No User Fee
Device type: Laparoscopic contraceptive tubal occlusion device (KNH) · Obstetrics & Gynecology
- ADIANA PERMANENT CONTRACEPTION SYSTEMPMA supplement
P070022-S019 · Decided May 27, 2011 · 44 days after receipt · Normal 180 Day Track No User Fee
Device type: Laparoscopic contraceptive tubal occlusion device (KNH) · Obstetrics & Gynecology
- ADIANA PERMANENT CONTRACEPTION SYSTEMPMA supplement
P070022-S002 · Decided Apr 15, 2010 · 45 days after receipt · Normal 180 Day Track No User Fee
Device type: Laparoscopic contraceptive tubal occlusion device (KNH) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Adiana Permanent Contraception", any status and sponsor, newest update first.
Hologic, Inc.Public (HOLX)
NCT00737061 · 770 participants · Start Nov 2002 · Primary completion Dec 2005
Device: Adiana Transcervical Sterilization System · For: Reproductive Sterilization
Sites: Phoenix, Arizona; Roseville, California; San Rafael, California · 16 sites in all
BayerNot on our public-company list
NCT02532361 · 10,578 participants · Start Aug 2015 · Primary completion Dec 2015
Device: Hysteroscopic device placement including Essure (ESS305, BAY1454032) · For: Hysterectomy
Sites: New Jersey, New Jersey
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Adiana Permanent Contraception", and for the whole product code for context.
This brand
6 reports: 0 malfunction, 6 injury, 0 death
Whole product code KNH
524 reports: 66 malfunction, 448 injury, 1 death
Newest reports for this brand
1222780-2022-00175 · Received Jul 1, 2022
Device type: Laparoscopic Contraceptive Tubal Occlusion Device (KNH)
Device problem as coded: Material Fragmentation; Migration or Expulsion of Device
Patient problem as coded: Abscess; Arthritis; Fatigue; Hair Loss; Headache; Unspecified Infection; Memory Loss/Impairment; Convulsion/Seizure; Syncope/Fainting
1222780-2022-00050 · Received Feb 17, 2022
Device type: Laparoscopic Contraceptive Tubal Occlusion Device (KNH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abdominal Pain; Pain; Intermenstrual Bleeding
1222780-2019-00031 · Received Feb 15, 2019 · Event dated Jan 25, 2019
Device type: Laparoscopic Contraceptive Tubal Occlusion Device (KNH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hair Loss; Pain; Rash; Sleep Dysfunction; Abdominal Cramps
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Adiana Permanent Contraception"[tiab]. The summary above synthesizes these.
- Transcervical sterilization.
Castaño PM, Adekunle L · Semin Reprod Med · 2010Review
- Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis.
la Chapelle CF, Veersema S, Brölmann HA, et al. · Fertil Steril · 2015Meta-Analysis, Systematic Review
- Procedural and clinical outcomes of Adiana® hysteroscopic tubal occlusion in the Netherlands.
van Gastel DM, Maassen LW, Van Erp MAJM, et al. · Facts Views Vis Obgyn · 2024
- A review of clinical data for currently approved hysteroscopic sterilization procedures.
Basinski CM · Rev Obstet Gynecol · 2010
- Unilateral placement of the Adiana device after failed bilateral placement of the Essure device for hysteroscopic sterilization.
Gimpelson RJ, Wagner CA · J Minim Invasive Gynecol · 2010Case Reports
- Mechanism of action of the Adiana(®) device: a histologic perspective.
Vancaillie TG, Harrington DC, Anderson JM · Contraception · 2011Multicenter Study, Research Support, Non-U.S. Gov't
- Successful placement of the Essure device after a failed procedure using the Adiana system for hysteroscopic sterilisation.
Schuurman T, Veersema S · BMJ Case Rep · 2011Case Reports
- State-of-the-art of non-hormonal methods of contraception: V. Female sterilisation.
Beerthuizen R · Eur J Contracept Reprod Health Care · 2010Historical Article, Systematic Review
Other devices of this type
Also filed under product code KNH.
- Filshie Clip (Mark VI) SystemFemcare , Ltd. · PMA 2024
- Falope-Ring Band Contraceptive Tubal Occlusion SystemGyrus Acmi, Inc. · PMA 2016
- Falope Ring Band and Applicator SystemsGyrus Acmi, Inc. · PMA 2017
- Adiana Contraception SystemHologic, Inc. · PMA 2012
- Acmi Falope Ring BandGyrus Acmi, Inc. · PMA 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.